medical-devices is the sole category represented across all 1 tracked stories. Cell Biomaterials is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Healthcare story that mention Lining Ju, all published on July 25, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Lining Ju
medical-devices is the sole category represented across all 1 tracked stories. Cell Biomaterials is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Healthcare story that mention Lining Ju, all published on July 25, 2026. Each carries 3 original sources on average.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Lining Ju. Shared-story counts are live from our verified record — not editorial picks.
A patient‑specific ‘artery‑on‑a‑chip’ that mimics a person’s carotid geometry and clotting behavior is set to revolutionize stroke risk prediction, especially for underserved populations. The technology, tested on six patients, could spare low‑risk individuals from unnecessary interventions while catching those at high risk. A clinical trial is now recruiting.